CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop FRANKFURT, Germany (AP) Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by mutual agreement with the companys board of directors, citing recent market challenges and a steep decline in the companys share price
Eat Smart Before Your Shot GLP-1s can cause nausea, especially if taken on an empty stomach or after a heavy, greasy meal
(Results Timeline Explained) Find out how long retatrutide takes to work, when results begin, and how to maximise fat loss with the right dosing and lifestyle habits
The short-term risks from dehydration and constipation are manageable with the prevention strategies outlined in this guide
I love being able to have help staying healthy and managing my weight
Ozempic rose from a 10 th place ranking among the 10 top-selling Part D drugs in 2021, with gross spending of $2.6 billion, to 6 th place in 2022, with spending of $4.6 billion (Figure 2)